Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.72 | 16.43 |
| PEG Ratio (TTM) | -1.24 | 2.14 |
| P/S Ratio (TTM) | 2.62 | 1.69 |
| P/B Ratio (TTM) | 2.31 | 3.05 |
| P/FCF Ratio (TTM) | -16.57 | 10.49 |
| Price to 5YR AVG Earnings Ratio | N/A | 2.72 |
| Price to 5YR AVG FCF Ratio | N/A | 33.37 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.12% | 7.46% |
| ROE (TTM) | 8.04% | 17.51% |
| Net Profit Margin (TTM) | 8.78% | 9.15% |
| ROIC 5YR AVG | N/A | 6.21% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -31.55% | 1,691.85% | N/A |
| Revenue | 20.29% | 87.14% | N/A |
| Net Income | -30.47% | 1,694.17% | N/A |
| Cash Flow | 23.08% | 326.95% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.23 | 1.84 |
| Quick Ratio (TTM) | 1.08 | 1.33 |
| D/E Ratio (TTM) | 0.45 | 1.07 |
| Interest Coverage (TTM) | 4.63 | 16.78 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 2.29 | 2.92 |
| LTL to 5YR AVG FCF | N/A | 8.37 |
| Shares Outstanding Growth 5YR AVG | N/A | 6.51% |